Etiqueta: multiple sclerosis

Autologous adult stem cell therapies that are routinely used for the treatment of injuries and degenerative conditions in dogs and horses are now being translated into human clinical trials.

Yet another American bravely decides to travel overseas for adult stem cell therapy that was pioneered by U.S. doctors but which is not available in the United States.

Once again, a U.S. citizen is forced to travel overseas for an adult stem cell therapy which was pioneered by U.S. doctors but which is not available in the United States.

A New York woman reports that her ten-year-old autistic daughter has significantly improved after receiving adult stem cell therapy in Germany.

The U.S. Patent and Trademark Office has awarded a patent to Pluristem Therapeutics for the invention of a novel method of expanding hemopoietic stem cells.

Scientists demonstrate that adult stem cells from bone grafts extend cardiac transplant survival through immune modulation.

In yet another merger of Big Pharma and academia, two of the world’s leading research entities join forces for combined stem cell R&D.

Three patients with multiple sclerosis show significant improvement after being treated with their own fat-derived adult stem cells.

Researchers unravel the cellular mechanisms of myelin formation from human embryonic stem cells.

Scientists demonstrate both safety and feasibility of an adult stem cell therapy for the treatment of spinal cord injuries.